Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospitalized for COVID-19 had improved outcomes compared to non-users.

Cannabinoids as Emergent Therapy Against COVID-19

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2(SARS-Cov-2), was identified for the first time in late 2019 in China, resulting in a global pandemic of massiveimpact. Despite a fast development and implementation of vaccination strategies, and the scouting of severalpharmacological treatments, alternative effective treatments are still needed. In this regard, cannabinoids repre-sent a promising approach because they have been proven to exhibit several immunomodulatory, anti-inflammatory, and antiviral properties in COVID-19 disease models and related pathological conditions. Thismini-review aims at providing a practical brief overview of the potential applications of cannabinoids so far iden-tified for the treatment and prevention of COVID-19, finally considering key aspects related to their technologicaland clinical implementation.

Synergy with Cannabis and Other Herbs: Thinking Beyond Plant Constituents

Explore the different types of plant synergy, herbs that may combine well with cannabis, and the healing properties of botanicals that science will never be able to fully explain.

Tic Disorder Management with Cannabis: A Family’s Tale Meets the Science

Dr. Genevieve Newton describes the state of the research on cannabis in the treatment of tic disorders and what her young son’s experience with cannabis has been like.

Cannabis as a Multifaceted Treatment Approach to Alzheimer’s Disease

Current treatments cannot stop or reverse the progression of the Alzhiemer’s disease. Learn how cannabis medicine may be a valid treatment option to alleviate the multitude of complex symptoms associated with this condition.

Cannabis Use Leads to Heart Attacks? Healthcare Providers Set the Record Straight

In an effort to set the record straight on the questionable conclusions presented in a recent cannabis and heart attack risk study, SCC Board Members Sherry Yafai, MD and Patricia C. Frye, MD weigh in with their observations and research evidence.

Mothers Give Insight on Navigating Medical Cannabis for their Children with Autism

The Society of Cannabis Clinicians interviews mothers of children with autism about their journey and how cannabis has played a role.

Cannabis Education in Communities of Color: An Opportunity for Healthcare Professionals

Inequality exists in all aspects of society, including incarceration, policing, medicine, research, and the cannabis industry. It is the duty of healthcare workers to heal communities in need and critique systems that cause harm.

Cannabis Consciousness, Alternative Healing, and the Medicine of Psychoactivity

Dustin Sulak, DO on cannabis consciousness, plant ritual and its healing potential, the benefits of psychoactivity, and other entheogenic allies for our current times.

SCC Consensus on Delta-8-THC

The SCC statement on delta-8-THC, its safety profile, and considerations for clinicians and patients.

Indigenous Empirical Plant Knowledge Meets Cannabis Science

Dr. Yesid Ramirez created a free, day-long intensive program on cannabis science at ICESI University in Cali, Colombia for historically discriminated indigenous groups.

In Memoriam: Honoring Dr. Jim Brent’s Multifaceted Approach to Cannabis

Dr. Brent was a retired dentist and an avid herbalist, which framed most of the perspective for his research on cannabis and integrating it into the greater botanical medicine compendium.